(NuVasive’s sales that year were $38 million.) And…the year NuVasive’s manager of interbody development, Jason Blain and his friend, one of the senior execs at CoorsTek, Inc., Todd Andres, quit their ...

Pat Miles, NuVasive’s President of the Americas, told OTW, "The letter by NASS provides a clear position from the definitive authority in spine surgery that lateral interbody fusion is a longstanding ...